Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1989
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1998 1
2002 1
2005 1
2006 1
2007 1
2010 1
2011 1
2018 1
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
Natalizumab and other monoclonal antibodies.
Ursell MR, O'Connor PW. Ursell MR, et al. Neurol Clin. 2005 Feb;23(1):233-46, viii. doi: 10.1016/j.ncl.2004.09.005. Neurol Clin. 2005. PMID: 15661096 Review. No abstract available.
Safety of vitamin D3 in adults with multiple sclerosis.
Kimball SM, Ursell MR, O'Connor P, Vieth R. Kimball SM, et al. Among authors: ursell mr. Am J Clin Nutr. 2007 Sep;86(3):645-51. doi: 10.1093/ajcn/86.3.645. Am J Clin Nutr. 2007. PMID: 17823429 Free article.
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.
Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P. Burton JM, et al. Among authors: ursell m. Neurology. 2010 Jun 8;74(23):1852-9. doi: 10.1212/WNL.0b013e3181e1cec2. Epub 2010 Apr 28. Neurology. 2010. PMID: 20427749 Free PMC article. Clinical Trial.
Clinical problem-solving. Heading down the wrong path.
Detsky ME, Chiu L, Shandling MR, Sproule ME, Ursell MR. Detsky ME, et al. Among authors: ursell mr. N Engl J Med. 2006 Jul 6;355(1):67-74. doi: 10.1056/NEJMcps044183. N Engl J Med. 2006. PMID: 16822998 No abstract available.
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.
Trojano M, Butzkueven H, Kappos L, Wiendl H, Spelman T, Pellegrini F, Chen Y, Dong Q, Koendgen H, Belachew S; Tysabri® Observational Program (TOP) Investigators. Trojano M, et al. Mult Scler Relat Disord. 2018 Aug;24:11-19. doi: 10.1016/j.msard.2018.04.020. Epub 2018 May 2. Mult Scler Relat Disord. 2018. PMID: 29860197 Free article.
11 results